How often does this podcast release new episodes?

This podcast updates bi-weekly.

Where can I listen to this podcast?

This podcast is available on 6 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Hu Said: Cardiology Board Review Series

Claim This Podcast

by Ruey Hu, MD, MPH

4.8(53 reviews)

111 episodes

Updated Bi-weekly

Accepts GuestsHas Sponsors

Podcast Overview

Welcome to Hu Said, a cardiology #MedEd podcast. Every episode cuts straight to the core of the topic, delivering the high-yield information you need to know for your exams. In this 2nd season of the podcast, new topics have been added, with >100 total topics. Whenever possible, evidence-based statements from the latest ACC/AHA/HRS/HFSA/SCAI guidelines are interwoven. Whether you are a resident, fellow, or re-certifying cardiologist, subscribe for precise, curated pearls. Ensure you get maximum knowledge in minimal time, because your time is valuable. X: @ruey_hu Materials: rueyhu.com/MedEd

Language

🇺🇲

Publishing Since

6/16/2024

Visit Website View on Apple Podcasts RSS Feed

1 verified contact email on file for Hu Said: Cardiology Board Review Series

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

March 14, 2026

2026 ACC/AHA Dyslipidemia Guideline

When should apoB be measured? In whom should lipoprotein(a) be measured? Should LDL-C be calculated by the Friedewald, Martin-Hopkins, or Sampson-NIH equations? How do the PREVENT-ASCVD equations differ from the Pooled Cohort Equations? How long is a coronary artery calcium (CAC) score of 0 "good for"? How should CAC scoring be used to guide statin initiation and intensity? What are the new LDL-C, non-HDL-C, and apoB targets for secondary prevention? What counts as "very high-risk" ASCVD, and how does treatment differ? In which patients should bempedoic acid, inclisiran, or olezarsen be added? Watch for answers to these key questions and more in this "deep dive" of the 2026 ACC/AHA Guideline on the Management of Dyslipidemia.Watch on YouTube: https://youtu.be/yHXL_dH8zCo Difficulty Level: Easy You are listening to Hu Said: Guideline LifelinePlease subscribe, rate, and support the channel! Ads help keep materials free for everyone.More MedEd resources available at <a href="https://www.rueyhu.com">⁠⁠⁠⁠www.rueyhu.com⁠⁠⁠⁠</a>Updates at Twitter/X: <a href="https://twitter.com/ruey_hu">⁠⁠⁠⁠@Ruey_Hu⁠</a>

February 21, 2026

2026 AHA/ACC Acute Pulmonary Embolism Guideline

What is the new 2026 classification for acute pulmonary embolism? What is the respiratory modifier? What category encompasses normotensive shock? What is the difference between the PESI score, sPESI score, Hestia score, and CPES score? Should LMWH or unfractionated heparin be used for initial parenteral anticoagulation for PE? What anticoagulation agent for PE is recommended in patients with antiphospholipid syndrome, chronic kidney disease, brain tumors, or pregnancy? In which patients is systemic lysis, catheter-directed thrombolysis, mechanical thrombectomy, or surgery appropriate? How should clot-in-transit be managed? Is there a role for pulmonary vasodilators? How should vasopressors be dosed in acute PE? How is CTEPD different from CTEPH? How long should anticoagulation be continued after PE? Watch for answers to these key questions in this "deep dive" of the 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults — the first-ever dedicated AHA/ACC guideline on acute PE.This episode also available on YouTube: https://youtu.be/rE-I4Jwq1UA Difficulty Level: Easy You are listening to Hu Said: Guideline LifelinePlease subscribe, rate, and support the channel! Ads help keep materials free for everyone.More MedEd resources available at <a href="https://www.rueyhu.com">⁠⁠⁠⁠⁠www.rueyhu.com⁠⁠⁠⁠⁠</a>Updates at Twitter/X: <a href="https://twitter.com/ruey_hu">⁠⁠⁠⁠⁠@Ruey_Hu⁠</a>

December 21, 2025

2025 ACC/AHA Adult Congenital Heart Disease Guideline

What right ventricular end-systolic volume should guide timing of pulmonary valve replacement in tetralogy of Fallot? At what pulmonary vascular resistance can closure be pursued for an atrial septal defect in patients with pulmonary hypertension? How often should Fontan patients receive liver imaging and alpha-fetoprotein screening? Should patients with Eisenmenger syndrome be routinely anticoagulated? What is the maternal mortality risk for pregnancy in Eisenmenger syndrome? Should most pregnant patients with adult congenital heart disease undergo cesarean delivery? Should cyanotic ACHD patients undergo prophylactic phlebotomy? Can ACHD patients participate in competitive sports? Watch for answers to these key questions in this "deep dive" of the 2025 ACC/AHA Guideline for the Management of Adults with Congenital Heart Disease.Difficulty Level: Advanced This episode also available on YouTube: https://youtu.be/IYTn5bjiHqY You are listening to Hu Said: Guideline LifelinePlease subscribe, rate, and support the channel! Ads help keep materials free for everyone.More MedEd resources available at <a href="https://www.rueyhu.com">⁠⁠⁠⁠www.rueyhu.com⁠⁠⁠⁠</a>Updates at Twitter/X: <a href="https://twitter.com/ruey_hu">⁠⁠⁠⁠@Ruey_Hu⁠</a>

111 total episodes available

Similar Podcasts

Discover related shows you might enjoy

Cardionerds: A Cardiology Podcast

CardioNerds

This Week in Cardiology

Medscape

Core IM | Internal Medicine Podcast

Core IM Team

JAMA Clinical Reviews

JAMA Network

Harrison's PodClass: Internal Medicine Cases and Board Prep

AccessMedicine

The Curbsiders Internal Medicine Podcast

The Clinical Problem Solvers

NEJM This Week

NEJM Group

The Daily

The New York Times

How to Be a Better Human

TED

ACC CardiaCast

American College of Cardiology

Last Week in Medicine

Stephen Jenkins, MD, Austin Rupp, MD

Heart Failure in Focus

Unknown author

Centeno-Schultz Clinic - Podcasts

Centeno-Schultz Clinic Staff

Deep-dive analytics for Hu Said: Cardiology Board Review Series

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Hu Said: Cardiology Board Review Series?: Welcome to Hu Said, a cardiology #MedEd podcast. Every episode cuts straight to the core of the topic, delivering the high-yield information you need to know for your exams. In this 2nd season of the podcast, new topics have been added, with >100 total topics. Whenever possible, evidence-based statements from the latest ACC/AHA/HRS/HFSA/SCAI guidelines are interwoven. Whether you are a resident, fellow, or re-certifying cardiologist, subscribe for precise, curated pearls. Ensure you get maximum knowledge in minimal time, because your time is valuable.

X: @ruey_hu Materials: rueyhu.com/MedEd
How often does this podcast release new episodes?: This podcast updates bi-weekly.
Where can I listen to this podcast?: This podcast is available on 6 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.